Levetiracetam versus Phenobarbitone in Neonatal Seizures — A Randomized Controlled Trial

To compare the efficacy and safety of intravenous Levetiracetam and Phenobarbitone in the treatment of neonatal seizures.Open labelled, Randomized controlled trial.Level III Neonatal Intensive Care Unit (NICU).100 neonates (0-28 days) with clinical seizures.If seizures persisted even after correction of hypoglycemia and hypocalcemia, participants were randomized to receive either Levetiracetam (20 mg/kg) or Phenobarbitone (20 mg/kg)...